Skip to main content

Neurology News – January 2022

January 11, 2022
What’s new in the Department of Neurology

FDA approves new drug to treat generalized myasthenia gravis

January 3, 2022
James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the phase 3 trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.

Diaz Receives AAN Clinical Research Training Scholarship

December 13, 2021
The American Academy of Neurology awarded Monica M. Diaz, MD, MS, a Clinical Research Training Scholarship in support of her research on the detection of neurodegeneration in older, cognitively impaired people with HIV.

James Ho receives Junior Faculty Development Award

November 30, 2021
James Pham Ho, MD, receives $10,000 Junior Faculty Development Award

Duke-UNC ADRC announces three research funding opportunities

November 10, 2021
The Duke/UNC ADRC is pleased to announce the release of three funding opportunities for researchers at Duke and UNC studying Alzheimer’s disease and related dementias. One of the awards, the REC Scholar, is also open to candidates from UNC Pembroke, North Carolina Central University, and East Carolina University.

Neurology News – November 2021

November 1, 2021
What’s new in the Department of Neurology

Fall 2021 – Message from the Chair

November 1, 2021
November 1, 2021 Fall often brings in a sense of the new. New school year with new students, new weather, new tree color, and new produce at the famers market. Within the Department of Neurology, we are also experiencing a lot of newness. The most profound change is the move...

Duke-UNC Alzheimer’s Disease Research Collaborative awarded major new funding as an NIH Alzheimer’s Disease Research Center

September 9, 2021
Areas of focus will include identifying age-related changes that impact the development, progression and experience of Alzheimer’s and related dementias, and how factors that arise in early- and mid-life contribute to racial, ethnic and geographic disparities in dementia.

UNC Neurology Receives New Center of Excellence Designation

September 1, 2021
The Division of Neuromuscular Disorders has been designated as a GBS|CIDP Foundation International Center of Excellence for the diagnosis and treatment of Guillain-Barre Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and other inflammatory peripheral neuropathies.

Neurology News – September 2021

August 31, 2021
What’s new in the Department of Neurology